Back to top
more

Alcon (ALC)

(Delayed Data from NYSE)

$75.63 USD

75.63
887,178

+0.97 (1.30%)

Updated Nov 30, 2023 04:00 PM ET

After-Market: $75.63 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.96%
2Buy17.61%
3Hold8.96%
4Sell4.80%
5Strong Sell2.32%
S&P50010.64%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (74 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

ALC or IDXX: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ALC vs. IDXX: Which Stock Is the Better Value Option?

Company News for Nov 16, 2023

by Zacks Equity Research

Companies In The News Are: ALC, XPEV, OLK, AAP.

Alcon (ALC) Q3 Earnings Miss Estimates, Margins Increase

by Zacks Equity Research

Alcon (ALC) Q3 revenues increase year over year, driven by strength in Surgical and Vision Care segments.

Alcon (ALC) Reports Q3 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

While the top- and bottom-line numbers for Alcon (ALC) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Here's Why Investors Should Buy Alcon (ALC) Stock Right Now

by Zacks Equity Research

Investors continue to be optimistic about Alcon (ALC), backed by a competitive product portfolio and strong commercial execution.

Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Alcon (ALC) and Alpine Immune Sciences, Inc. (ALPN) have performed compared to their sector so far this year.

Alcon (ALC) Unveils New Progress in Presbyopia Correcting IOLs

by Zacks Equity Research

Alcon's (ALC) Clareon Vivity IOL highlights proven results and high levels of patient satisfaction. It will offer a similar halo profile compared with a monofocal IOL.

Zacks Industry Outlook Highlights Alcon, STERIS and Inari Medical

by Zacks Equity Research

Alcon, STERIS and Inari Medical are part of the Zacks Industry Outlook article.

Urmimala Biswas headshot

3 Medical Instruments Stocks Countering Industry-Wide Headwinds

by Urmimala Biswas

The Zacks Medical - Instruments industry is being affected by ongoing inflation and a tightening monetary policy. However, the rising demand for digital health offers some respite. ALC, STE and NARI are poised to brave the challenges.

Are Medical Stocks Lagging Alcon (ALC) This Year?

by Zacks Equity Research

Here is how Alcon (ALC) and Alpine Immune Sciences, Inc. (ALPN) have performed compared to their sector so far this year.

Intuitive Surgical (ISRG) Q3 Earnings Beat, Procedures Robust

by Zacks Equity Research

Intuitive Surgical's (ISRG) third-quarter results reflect healthy demand for procedures, partially offset by lower system sales. Higher pricing boosted procedure sales.

Philips (PHG) Aids Clinicians With New Monitoring Solution

by Zacks Equity Research

Philips (PHG) launches Visual Patient Avatar to help anesthesiologists with situational awareness in operating rooms, boosting their clinical confidence.

Alcon (ALC) Stock Up 9.7% YTD: Will the Rally Continue?

by Zacks Equity Research

Alcon (ALC) continues gaining from the company's diverse portfolio, incremental innovation, and new product launches.

Here's Why You Should Hold Centene (CNC) in Your Portfolio

by Zacks Equity Research

Robust revenue growth outlook, contract wins, accretive acquisitions and streamlining of businesses poise Centene (CNC) well for growth.

Alcon (ALC) Gains From Growing Market Demand, New Launches

by Zacks Equity Research

Within Vision Care, Alcon (ALC) is registering solid growth, banking on strong sales of its contact lenses and ocular health products.

Centene (CNC) Eyes Membership Growth With 2024 Expansion Plans

by Zacks Equity Research

Centene (CNC) declares the availability of a varied set of health plans across new counties in 2024. It, thereby, places intensified focus on growing its Medicare business.

Alcon (ALC) Expands Optical Care Line With Latest Launch

by Zacks Equity Research

Alcon's (ALC) new TOTAL30 Multifocal lens outwits digital device dryness by delivering nearly 100% water at the lens's surface via a patented Water Gradient Technology.

Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Alcon (ALC) and Cardinal Health (CAH) have performed compared to their sector so far this year.

Waters (WAT) Boosts Mass Spectrometry Clientele With Latest Move

by Zacks Equity Research

Waters (WAT) partners with the University of San Agustin to provide the latter with technology equipment in its newly developed mass spectrometry imaging center in the Philippines.

Humana's (HUM) 2024 MA Plans Promise a Wider Set of Benefits

by Zacks Equity Research

Humana (HUM) aims to expand the reach of its Medicare plans across newer U.S. counties in 2024 through integrating multiple lucrative benefits within them.

Alcon (ALC) Loses -6.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

by Zacks Equity Research

Alcon (ALC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Indrajit Bandyopadhyay headshot

Protect Your Portfolio From Volatility With 3 Low-Beta Picks

by Indrajit Bandyopadhyay

At this stage, it is prudent to invest in low-beta stocks with a favorable Zacks Rank like ALC, RDY and ANIK, as these will be less volatile than the broader market.

Here's Why Investors Should Retain Acadia Healthcare (ACHC)

by Zacks Equity Research

Acadia Healthcare (ACHC) is well-poised for growth on the solid demand for behavioral healthcare services, the continuous pursuit of expansion initiatives and growing cash reserves.

Is Alcon (ALC) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Alcon (ALC) and Molina (MOH) have performed compared to their sector so far this year.

Here's Why Investors Should Buy Alcon (ALC) Stock Right Now

by Zacks Equity Research

Investors continue to be optimistic about Alcon (ALC) on the impressive performance of its portfolio.